Product Information
BEVESPI AEROSPHERE INHALER is a brand product labeled by AstraZeneca Pharmaceuticals LP, priced at $40.8758 per GM under NDC 00310460012. Its NADAC has been published 484 times since Mar 22, 2017.
Strength
4.8; 9 ug/1; ug/1
Manufacturer
AstraZeneca Pharmaceuticals LPNDC
00310460012
Classification
Brand
Dosage Form
AEROSOL, METERED
Route
RESPIRATORY (INHALATION)
Last Updated
6/17/2026
Active Ingredients
FORMOTEROL FUMARATE; GLYCOPYRROLATEApproval Type
New Drug (NDA)
FDA Application
NDA208294On Market Since
10/3/2016
Pharmacological Classes
Price Statistics
The NADAC for BEVESPI AEROSPHERE INHALER has been published 484 times since Mar 22, 2017, and over the history we have for it it has risen 36.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $40.8758 per GM |
|---|---|
| All-time high | $40.9856 (May 13, 2026) |
| All-time low | $30.0343 (Mar 22, 2017) |
| 52-week high | $40.9856 |
| 52-week low | $39.7794 |
| Median price | $35.4750 |
| Average price | $35.5728 |
| Largest weekly change | +6.0% (Jan 10, 2018) |
| Weeks tracked | 484 |
| Tracking since | Mar 22, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Glycopyrrolate and formoterol fumarate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of BEVESPI AEROSPHERE INHALER?
The current National Average Drug Acquisition Cost (NADAC) for BEVESPI AEROSPHERE INHALER, manufactured by AstraZeneca Pharmaceuticals LP, is $40.8758 per GM (NDC 00310460012), effective Jun 24, 2026.
How has the price of BEVESPI AEROSPHERE INHALER changed over time?
Over the history we have for it, the NADAC for BEVESPI AEROSPHERE INHALER has risen 36.1%. It has been tracked across 484 weekly CMS publications since Mar 22, 2017.
What are the highest and lowest recorded NADAC prices for BEVESPI AEROSPHERE INHALER?
Since Mar 22, 2017, the NADAC for BEVESPI AEROSPHERE INHALER has ranged from a low of $30.0343 (Mar 22, 2017) to a high of $40.9856 (May 13, 2026), with a median of $35.4750 per GM.
Are there cheaper alternatives to BEVESPI AEROSPHERE INHALER?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of BEVESPI AEROSPHERE INHALER, so no direct lower-cost alternative is listed.
Who manufactures BEVESPI AEROSPHERE INHALER?
BEVESPI AEROSPHERE INHALER (NDC 00310460012) is labeled by AstraZeneca Pharmaceuticals LP, and CMS classifies it as a brand product.
Related Drugs
Same classification